vs
Side-by-side financial comparison of EXELIXIS, INC. (EXEL) and Bristow Group Inc. (VTOL). Click either name above to swap in a different company.
EXELIXIS, INC. is the larger business by last-quarter revenue ($598.7M vs $377.3M, roughly 1.6× Bristow Group Inc.). EXELIXIS, INC. runs the higher net margin — 40.8% vs 4.9%, a 36.0% gap on every dollar of revenue. On growth, Bristow Group Inc. posted the faster year-over-year revenue change (6.7% vs 5.6%). EXELIXIS, INC. produced more free cash flow last quarter ($332.4M vs $47.8M). Over the past eight quarters, EXELIXIS, INC.'s revenue compounded faster (18.7% CAGR vs 5.8%).
Exelixis, Inc. is a genomics-based drug discovery company located in Alameda, California, and the producer of Cometriq, a treatment approved by the U.S. Food and Drug Administration (FDA) for medullary thyroid cancer with clinical activity in several other types of metastatic cancer.
Bristow Helicopters Limited is a British civil helicopter operator originally based at Aberdeen Airport, Scotland, which is currently a part of the U.S.-based Bristow Group which in turn has its corporate headquarters in Houston, Texas, U.S. In 2020, Bristow Group was merged with Era Helicopters, a large U.S.-based commercial helicopter operator that was previously a division of Era Aviation, with the two companies then continuing to use the Bristow name.
EXEL vs VTOL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $598.7M | $377.3M |
| Net Profit | $244.5M | $18.4M |
| Gross Margin | 95.6% | — |
| Operating Margin | 39.3% | 8.5% |
| Net Margin | 40.8% | 4.9% |
| Revenue YoY | 5.6% | 6.7% |
| Net Profit YoY | 74.8% | -42.1% |
| EPS (diluted) | $0.89 | $0.61 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $598.7M | — | ||
| Q4 25 | $597.8M | $377.3M | ||
| Q3 25 | $568.3M | $386.3M | ||
| Q2 25 | $555.4M | $376.4M | ||
| Q1 25 | $566.8M | $350.5M | ||
| Q4 24 | — | $353.5M | ||
| Q3 24 | $539.5M | $365.1M | ||
| Q2 24 | $637.2M | $359.7M |
| Q1 26 | $244.5M | — | ||
| Q4 25 | $193.6M | $18.4M | ||
| Q3 25 | $184.8M | $51.5M | ||
| Q2 25 | $159.6M | $31.7M | ||
| Q1 25 | $139.9M | $27.4M | ||
| Q4 24 | — | $31.8M | ||
| Q3 24 | $118.0M | $28.2M | ||
| Q2 24 | $226.1M | $28.2M |
| Q1 26 | 95.6% | — | ||
| Q4 25 | 96.9% | — | ||
| Q3 25 | 96.6% | — | ||
| Q2 25 | 96.5% | — | ||
| Q1 25 | 96.5% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 96.8% | — | ||
| Q2 24 | 97.2% | — |
| Q1 26 | 39.3% | — | ||
| Q4 25 | 39.6% | 8.5% | ||
| Q3 25 | 37.6% | 13.1% | ||
| Q2 25 | 33.6% | 11.3% | ||
| Q1 25 | 28.8% | 9.6% | ||
| Q4 24 | — | 9.0% | ||
| Q3 24 | 25.2% | 9.1% | ||
| Q2 24 | 43.3% | 12.4% |
| Q1 26 | 40.8% | — | ||
| Q4 25 | 32.4% | 4.9% | ||
| Q3 25 | 32.5% | 13.3% | ||
| Q2 25 | 28.7% | 8.4% | ||
| Q1 25 | 24.7% | 7.8% | ||
| Q4 24 | — | 9.0% | ||
| Q3 24 | 21.9% | 7.7% | ||
| Q2 24 | 35.5% | 7.8% |
| Q1 26 | $0.89 | — | ||
| Q4 25 | $0.69 | $0.61 | ||
| Q3 25 | $0.65 | $1.72 | ||
| Q2 25 | $0.55 | $1.07 | ||
| Q1 25 | $0.47 | $0.92 | ||
| Q4 24 | — | $1.07 | ||
| Q3 24 | $0.40 | $0.95 | ||
| Q2 24 | $0.77 | $0.96 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.1B | $286.2M |
| Total DebtLower is stronger | — | $671.5M |
| Stockholders' EquityBook value | $2.2B | $1.1B |
| Total Assets | $2.8B | $2.3B |
| Debt / EquityLower = less leverage | — | 0.63× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $1.1B | — | ||
| Q4 25 | $988.5M | $286.2M | ||
| Q3 25 | $791.1M | $245.5M | ||
| Q2 25 | $1.0B | $251.8M | ||
| Q1 25 | $1.1B | $191.1M | ||
| Q4 24 | — | $247.5M | ||
| Q3 24 | $1.2B | $200.3M | ||
| Q2 24 | $1.0B | $178.6M |
| Q1 26 | — | — | ||
| Q4 25 | — | $671.5M | ||
| Q3 25 | — | $675.0M | ||
| Q2 25 | — | $705.2M | ||
| Q1 25 | — | $701.9M | ||
| Q4 24 | — | $689.8M | ||
| Q3 24 | — | $629.1M | ||
| Q2 24 | — | $594.2M |
| Q1 26 | $2.2B | — | ||
| Q4 25 | $2.2B | $1.1B | ||
| Q3 25 | $2.0B | $1.0B | ||
| Q2 25 | $2.1B | $984.4M | ||
| Q1 25 | $2.2B | $931.7M | ||
| Q4 24 | — | $891.7M | ||
| Q3 24 | $2.3B | $899.2M | ||
| Q2 24 | $2.1B | $849.1M |
| Q1 26 | $2.8B | — | ||
| Q4 25 | $2.8B | $2.3B | ||
| Q3 25 | $2.7B | $2.3B | ||
| Q2 25 | $2.8B | $2.3B | ||
| Q1 25 | $2.9B | $2.2B | ||
| Q4 24 | — | $2.1B | ||
| Q3 24 | $3.0B | $2.1B | ||
| Q2 24 | $2.8B | $2.0B |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.63× | ||
| Q3 25 | — | 0.65× | ||
| Q2 25 | — | 0.72× | ||
| Q1 25 | — | 0.75× | ||
| Q4 24 | — | 0.77× | ||
| Q3 24 | — | 0.70× | ||
| Q2 24 | — | 0.70× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $333.5M | $76.9M |
| Free Cash FlowOCF − Capex | $332.4M | $47.8M |
| FCF MarginFCF / Revenue | 55.5% | 12.7% |
| Capex IntensityCapex / Revenue | 0.2% | 7.7% |
| Cash ConversionOCF / Net Profit | 1.36× | 4.17× |
| TTM Free Cash FlowTrailing 4 quarters | $875.8M | $56.4M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $333.5M | — | ||
| Q4 25 | $290.3M | $76.9M | ||
| Q3 25 | $49.0M | $23.1M | ||
| Q2 25 | $211.4M | $99.0M | ||
| Q1 25 | $240.3M | $-603.0K | ||
| Q4 24 | — | $51.1M | ||
| Q3 24 | $271.3M | $66.0M | ||
| Q2 24 | $119.5M | $33.7M |
| Q1 26 | $332.4M | — | ||
| Q4 25 | $288.8M | $47.8M | ||
| Q3 25 | $46.2M | $-6.2M | ||
| Q2 25 | $208.5M | $67.4M | ||
| Q1 25 | $236.3M | $-52.7M | ||
| Q4 24 | — | $-32.4M | ||
| Q3 24 | $263.1M | $9.0M | ||
| Q2 24 | $113.0M | $-16.7M |
| Q1 26 | 55.5% | — | ||
| Q4 25 | 48.3% | 12.7% | ||
| Q3 25 | 8.1% | -1.6% | ||
| Q2 25 | 37.5% | 17.9% | ||
| Q1 25 | 41.7% | -15.0% | ||
| Q4 24 | — | -9.2% | ||
| Q3 24 | 48.8% | 2.5% | ||
| Q2 24 | 17.7% | -4.6% |
| Q1 26 | 0.2% | — | ||
| Q4 25 | 0.2% | 7.7% | ||
| Q3 25 | 0.5% | 7.6% | ||
| Q2 25 | 0.5% | 8.4% | ||
| Q1 25 | 0.7% | 14.9% | ||
| Q4 24 | — | 23.6% | ||
| Q3 24 | 1.5% | 15.6% | ||
| Q2 24 | 1.0% | 14.0% |
| Q1 26 | 1.36× | — | ||
| Q4 25 | 1.50× | 4.17× | ||
| Q3 25 | 0.27× | 0.45× | ||
| Q2 25 | 1.32× | 3.12× | ||
| Q1 25 | 1.72× | -0.02× | ||
| Q4 24 | — | 1.61× | ||
| Q3 24 | 2.30× | 2.34× | ||
| Q2 24 | 0.53× | 1.20× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EXEL
| Cabometyx | $544.7M | 91% |
| Collaboration | $52.1M | 9% |
| Collaborative Arrangementwith Takeda | $5.9M | 1% |
| Cometriq | $1.8M | 0% |
VTOL
| Offshore Energy Services | $247.5M | 66% |
| Government Services | $100.1M | 27% |
| Other | $21.9M | 6% |
| Related Party | $7.8M | 2% |
